The immune cells that participate in the pathogenesis of RA often enhance osteoclastogenesis by upregulating RANKL directly or by secreting proinflammatory cytokines that influence RANKL expression indirectly. The gene discussed is TNFSF11; the disease is rheumatoid arthritis.